Synthemed – Compensation Arrangement Mr. John Benson (March 31st, 2015)
Effective March 1, 2015, the annual salary to which Mr. John Benson is entitled under his employment agreement with Pathfinder Cell Therapy, Inc. has been reduced to $73,000.
Synthemed – [ University of Glasgow Letterhead ] (April 30th, 2013)
We refer to our recent discussions regarding the research agreement between The University Court of the University of Glasgow (the University) and Pathfinder, LLC (now a wholly owned subsidiary of Pathfinder Cell Therapy, Inc., previously known as SyntheMed, Inc.) (the Company) (contract no. 49974/1) dated 23 March 2009, as extended by way of an extension letter from the University to the Company dated 19 April 2012 (the Research Agreement). Terms defined in the Research Agreement will have the same meaning where used herein.